(Q37901418)

25 August 2017

1 reference

title

Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies (English)

1 reference

25 August 2017

0 references

1 reference

Holland HK

1

1 reference

25 August 2017

Wingard JR

series ordinal

2

1 reference

25 August 2017

Saral R

series ordinal

3

1 reference

25 August 2017

publication date

1 January 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

5

1 reference

25 August 2017

page(s)

509-521

1 reference

Cell-Mediated Immunity to Cytomegalovirus Infection in Normal Subjects and Cardiac Transplant Patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

The biology of human cytomegalovirus infection after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Cytomegalovirus-seronegative blood components for the prevention of primary cytomegalovirus infection after marrow transplantation. Considerations for blood banks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements forin vitro generation and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Acyclovir prophylaxis of herpes-simplex-virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Clinical resistance to acyclovir of herpes simplex virus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

A Longitudinal Study of Varicella-Zoster Virus Infections in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Infection with varicella-zoster virus after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Development and Characteristics of the Cellular Immune Response to Infection with Varicella-Zoster Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Evaluation of zoster immune plasma. Treatment of cutaneous disseminated zoster in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Outbreak of Coxsackie A1 gastroenteritis: a complication of bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

Adenovirus infections in patients undergoing bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

BK and JC virus infections in recipients of bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909009012076

10.3109/07357909009012076

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference